Taféro EM (Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg) PREP to reduce the risk of HIV infection

Product Name: Taféro EM (Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg)
Brand: Hetero Healthcare

Description:
Taféro EM is a combination antiretroviral medication containing Emtricitabine (200 mg) and Tenofovir Alafenamide (25 mg). It is used in the management of HIV infection and as a preventive measure against HIV.

Indications:

• HIV antiviral treatment (not typically first-line therapy)
• Pre-Exposure Prophylaxis (PrEP) to reduce the risk of HIV infection

Dosage & Administration:

• Take one tablet once daily
• Should be taken at the same time each day for best effectiveness

Packaging:

• 30 tablets per bottle
• Total strength per tablet: 225 mg

Important Notes:

• Must be used under medical supervision
• Adherence to daily dosing is essential for effectiveness
• Regular monitoring and follow-up are recommended